New Core Gant Guideline Proposals Drawn Up; Opposition Developing Among Center Directors
In Brief: $100 Million Being Spent On Interferon In U.S., Rauscher Says; DeVita; Criticism Deserved
Ax Falls; Recision Asked Of $17 Million For NCI This Year, $42.7 Million Cut In FY 1981 Budget
Cooperative Groups Other Investigators To Get Interferon When Available; DCT Recompetitions Okayed
GAO Offers Two Suggestions For Plant Screening
Trending Stories
- Is it time to re-assess the practice and practicality of screening colonoscopy?
Modeling data, ACS guideline support greater use of noninvasive tests to ease system strain, help save lives - From “default dead” to living the future of cancer care
As founding CEO of GitLab, I went “founder mode” on my osteosarcoma - As daraxonrasib hits the clinic, Frank McCormick says RAS is bigger than pancreatic cancer
- KRAS pioneer and Stephenson Prize winner Frank McCormick aims to prevent all KRAS cancers with a pill
- Brian Wolpin celebrates FDA approval of daraxonrasib in pancreatic cancer as the future of the field
- Mount Sinai oncologist Krystal Cascetta, 40, and her infant daughter die in Somers, NY, home









